human bladder cancer cell line umuc3 Search Results


human invasive bladder cancer (t24, ht-1376, j82, umuc-3, rt4 and tccsup) cell lines  (tiangen biotech co)
90
tiangen biotech co human invasive bladder cancer (t24, ht-1376, j82, umuc-3, rt4 and tccsup) cell lines
Human Invasive Bladder Cancer (T24, Ht 1376, J82, Umuc 3, Rt4 And Tccsup) Cell Lines, supplied by tiangen biotech co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human invasive bladder cancer (t24, ht-1376, j82, umuc-3, rt4 and tccsup) cell lines/product/tiangen biotech co
Average 90 stars, based on 1 article reviews
human invasive bladder cancer (t24, ht-1376, j82, umuc-3, rt4 and tccsup) cell lines - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
human bladder cancer cell line umuc3  (DS Pharma Biomedical)
90
DS Pharma Biomedical human bladder cancer cell line umuc3
Analysis of gemcitabine resistance of the bladder cancer cell lines. Bladder cancer cells were treated with gemcitabine for 72 h and cell viability was analyzed using CCK-8. The viability of parental <t>UMUC3</t> (A) and HT1376 (B) cells was respectively suppressed compared to (A) UMUC3GR and (B) HT1376GR by treatment with gemcitabine in a dose-dependent manner. Values are expressed as means ± standard deviation.
Human Bladder Cancer Cell Line Umuc3, supplied by DS Pharma Biomedical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human bladder cancer cell line umuc3/product/DS Pharma Biomedical
Average 90 stars, based on 1 article reviews
human bladder cancer cell line umuc3 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


Analysis of gemcitabine resistance of the bladder cancer cell lines. Bladder cancer cells were treated with gemcitabine for 72 h and cell viability was analyzed using CCK-8. The viability of parental UMUC3 (A) and HT1376 (B) cells was respectively suppressed compared to (A) UMUC3GR and (B) HT1376GR by treatment with gemcitabine in a dose-dependent manner. Values are expressed as means ± standard deviation.

Journal: Oncology Letters

Article Title: Silencing of ECHDC1 inhibits growth of gemcitabine-resistant bladder cancer cells

doi: 10.3892/ol.2017.7269

Figure Lengend Snippet: Analysis of gemcitabine resistance of the bladder cancer cell lines. Bladder cancer cells were treated with gemcitabine for 72 h and cell viability was analyzed using CCK-8. The viability of parental UMUC3 (A) and HT1376 (B) cells was respectively suppressed compared to (A) UMUC3GR and (B) HT1376GR by treatment with gemcitabine in a dose-dependent manner. Values are expressed as means ± standard deviation.

Article Snippet: Cell culture The human bladder cancer cell lines, UMUC3 and HT1376, which were used in this study, were purchased from DS Pharma Biomedical (Osaka, Japan).

Techniques: CCK-8 Assay, Standard Deviation

Proteins with increased expression in gemcitabine-resistant cells identified using iTRAQ proteomic analysis.

Journal: Oncology Letters

Article Title: Silencing of ECHDC1 inhibits growth of gemcitabine-resistant bladder cancer cells

doi: 10.3892/ol.2017.7269

Figure Lengend Snippet: Proteins with increased expression in gemcitabine-resistant cells identified using iTRAQ proteomic analysis.

Article Snippet: Cell culture The human bladder cancer cell lines, UMUC3 and HT1376, which were used in this study, were purchased from DS Pharma Biomedical (Osaka, Japan).

Techniques: Expressing, Multiplex sample analysis, Histone Deacetylase Assay

ECHDC1 protein expression in gemcitabine resistant and sensitive cell lines. (A) ECHDC1 protein expression levels in parental and gemcitabine resistant (GR) cell lines were determined using western blotting. ECHDC1 expression levels were clearly increased in the gemcitabine-resistant cells compared to the gemcitabine-sensitive cells. (B) Immunofluorescence analysis of ECHDC1 expression (red) in the indicated cells. Nuclei were counterstained with Hoechst 33342 (blue). The red signal in the cytoplasm, reflecting ECHDC1 expression, was much stronger in UMUC3GR than in UMUC3 cells.

Journal: Oncology Letters

Article Title: Silencing of ECHDC1 inhibits growth of gemcitabine-resistant bladder cancer cells

doi: 10.3892/ol.2017.7269

Figure Lengend Snippet: ECHDC1 protein expression in gemcitabine resistant and sensitive cell lines. (A) ECHDC1 protein expression levels in parental and gemcitabine resistant (GR) cell lines were determined using western blotting. ECHDC1 expression levels were clearly increased in the gemcitabine-resistant cells compared to the gemcitabine-sensitive cells. (B) Immunofluorescence analysis of ECHDC1 expression (red) in the indicated cells. Nuclei were counterstained with Hoechst 33342 (blue). The red signal in the cytoplasm, reflecting ECHDC1 expression, was much stronger in UMUC3GR than in UMUC3 cells.

Article Snippet: Cell culture The human bladder cancer cell lines, UMUC3 and HT1376, which were used in this study, were purchased from DS Pharma Biomedical (Osaka, Japan).

Techniques: Expressing, Western Blot, Immunofluorescence